DiscoveryProbe™ Anti-cancer Co
mpound Library-DiscoveryProbe™ Anti-cancer Compound Library- ￥33
- APExBIO
- 美国
- APE-L1023-096
- 2025年07月12日
企业认证
相关产品推荐更多 >
4-（a，β）-羟基金刚烷胺,4-(a,β)-Hydroxy Rimantadine,CAS：117821-36-0
￥11nPOC-POC替诺福韦（非对映异构体混合物）,nPOC-POC Tenofovir (Mixture of Diastereomers),CAS：1217542-13-6
￥11
Recombinant Murine Betacellulin-Recombinant Murine Betacellulin
￥33
Bovine Serum Albumin – Heat Shock, Reagent Grade, pH 7.0/Bovine Serum Albumin – Heat Shock, Reagent Grade, pH 7.0/Bovine Serum Albumin – Heat Shock, Reagent Grade, pH 7.0
询价
c-Cbl（C 端区域）/c-Cbl (C-terminal region)
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
该DiscoveryProbe™ Anti-cancer Compound Library产品的保存方式具体查看产品。
- 保质期：
1年
- 英文名：
DiscoveryProbe™ Anti-cancer Compound Library
- 库存：
100
- 供应商：
艾美捷科技
- CAS号：
无
- 规格：
100uL/well(10 mM solution),96 Well Deep Well Plate
DiscoveryProbe™ Anti-cancer Compound Library，DiscoveryProbe™ Anti-cancer Compound Library，DiscoveryProbe™ Anti-cancer Compound Library,DiscoveryProbe™ Anti-cancer Compound Library
DiscoveryProbe™ Anti-cancer Compound Library-DiscoveryProbe™ Anti-cancer Compound Library
产品货号：APE-L1023-096
产品规格：100uL/well(10 mM solution),96 Well Deep Well Plate
1164个抗癌化合物
Screening Library
DiscoveryProbe™ Anti-cancer Compound Library-DiscoveryProbe™ Anti-cancer Compound Library该DiscoveryProbe™ Anti-cancer Compound Library产品的保存方式具体查看产品。
点击：DiscoveryProbe™ Anti-cancer Compound Library-DiscoveryProbe™ Anti-cancer Compound Library查看更详细产品说明，更多应用、储存、价格、货期等信息请垂询艾美捷科技有限公司。更多APExBIO公司特色小分子抑制剂等产品评论，请点击查看艾美捷特色产品中心。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验stimulation. In addition, application of cell based assays simultaneously permits entry level evaluation of compound toxicity and endows with a powerful approach to perform high-throughput screenings of, e.g., small molecule libraries in a quest for novel
An Engineered Peptide Compound Platform Technology Incorporating Angiopep for Crossing the BBB
family is the base of the engineered peptide compound (EPiC) platform technology allowing the synthesis of compounds which enter the central nervous system (CNS) to treat brain disorders. Using the EPiC platform, active drugs are modified by incorporation
Multiple Cell Lines Using Quantum Dots
from a particular assay procedure, resulting in a significant reduction in the overall cost of a chemical compound library screen. By labeling live cells with Qtracker™ cell labeling kits and identifying cell proliferation using an Acumen Explorer� microplate
技术资料暂无技术资料 索取技术资料
